Innocoll

Description

• Innocoll is dedicated to making better happenbetter ways for patients to recover from surgeries, better ways to treat limb-threatening infections. In short, we are about engineering better medicines to help patients get better.Our proprietary, biocompatible, and biodegradable collagen-based products are precision-engineered for targeted use. Applied locally to wound and/or surgery sites, they are designed to provide a range of treatment benefits.Our late-stage product pipeline is focused on addressing a number of significant unmet medical needs: INL-001 (Bupivacaine-collagen bioresorbable implant) (Phase III) is being studied to deliver more effective treatment of post-operative pain; INL-002 (Gentamicin-collagen topical matrix) (Phase III) is being investigated as a topical treatment to better cure diabetic foot infections; and INL-003 (Bioresorbable collagen film surgical adhesion barrier) (scheduled to enter clinical studies in the US; approved ex-US).Our currently approved products include: COLLAGUARD (ex-US), COLLATAMP® G, SEPTOCOLL® E, REGENEPRO®, COLLACARE®, COLLEXA®, and ZORPREVA®, some of which are sold globally through strategic partnerships. All of our native collagen productsfrom extraction/purification of type-1 collagen through final delivery formare manufactured at our certified, integrated plant in Saal, Germany.
• 

  Headquarters:3813 W Chester Pike , Newtown Square, Pennsylvania, United States

  More
• 

  Phone Number: +1 484-406-5200

• 

  Website: https://www.innocoll.com

• 

  Employees:26

• 

  Revenue:$1 - 10M

• 

  Legal Name:Innocoll

• Innocoll's Social Media

  
• Is this data correct?

• |  NAICS Code: 325412  |

  Show More